Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Angiogenesis Induced By Aminoacyl-tRNA Synthetase Deficiency Is Dependent on Amino Acid Response (AAR) but Not Unfolded Protein Response (UPR) Pathways

Fan Zhang, Yi Chen, Yi Jin, Chun-Hui Xu, Dian-Jia Liu, Ai-Ning Xu, Yuan-Liang Zhang, Yin-Yin Xie, Jing-Yi Shi, Lan Wang, MD, Qiu-Hua Huang, Zhu Chen, Sai-Juan Chen, Xiao-Jian Sun, PhD

Blood (2018) 132 (Supplement 1): 77.

https://doi.org/10.1182/blood-2018-99-117909

Published: 2018

Journal Articles

Domain-Focused CRISPR-Cas9 Screen Identifies Hri Kinase As a Regulator of Fetal Hemoglobin in Adult Human Erythroid Cells

Jeremy D. Grevet, Nicole Hamagami, Xianjiang Lan, PhD, Laavanya Sankaranarayanan, MS, Saurabh Bhardwaj, PhD, Carolyne Face, David Posocco, Osheiza Abdulmalik, DVM, Cheryl A. Keller, PhD, Belinda Giardine, Simone Sidoli, PhD, Ben Garcia, PhD, Stella T Chou, MD, Ross C Hardison, PhD, Chris Vakoc, MD PhD, Junwei Shi, PhD, Gerd A. Blobel, MD PhD

Blood (2017) 130 (Supplement 1): 536.

https://doi.org/10.1182/blood.V130.Suppl_1.536.536

Published: 2017

Journal Articles

Identification of Imatinib-Sensitizing Genes in Chronic Myeloid Leukemia with a Genome-Scale Crispr Knock-out Screen

Matthieu Lewis, MD, Valerie Prouzet-Mauleon, Elodie Richard, Beatrice Turcq, Richard Iggo, MD PhD, Francois-xavier Mahon, MD PhD

Blood (2016) 128 (22): 4233.

https://doi.org/10.1182/blood.V128.22.4233.4233

Published: 2016

Journal Articles

Abnormal Expression of Friend Leukemia Virus Integration 1 (Fli1) Protein Is An Adverse Prognostic Factor In AML.

Steven M. Kornblau, MD, Yi Hua Qiu, MD, Nianxiang Zhang, Ph.D, Kevin R Coombes, Dennis K. Watson, BS, PhD

Blood (2010) 116 (21): 1674.

https://doi.org/10.1182/blood.V116.21.1674.1674

Published: 2010

Journal Articles

Constitutive Activation of FRAP/mTOR Pathway in Pediatric Anaplastic Large Cell Lymphomas: Potential Role as a Therapeutic Target.

Megan S. Lim, MD, PhD, Charles Seiler, Sheryl Tripp, Sherrie L. Perkins, MD PhD, Mitchell S. Cairo, MD, Kojo S. Elenitoba-Johnson, MD

Blood (2006) 108 (11): 290.

https://doi.org/10.1182/blood.V108.11.290.290

Published: 2006

Journal Articles

Endoplasmic Reticulum Stress Is a Target for Therapy in Waldenstrom’s Macroglobulinemia (WM).

Xavier Leleu, MD, Lian Xu, Zachary R. Hunter, Xiaoying Jia, Anne-Sophie Moreau, MD, Allen W. Ho, Evdoxia Hatjiharissi, MD, Hai N’Go, Daniel D. Santos, MD, Kelly O’Connor, Robert Manning, Jacob Soumerai, Christopher Patterson, Irene M. Ghobrial, MD, Steven P. Treon, MD

Blood (2006) 108 (11): 4641.

https://doi.org/10.1182/blood.V108.11.4641.4641

Published: 2006

Journal Articles

RAX Activates Tumor Suppressor p53.

Yu Pan, PhD, Richard L. Bennett, Ph.D., W. Stratford May, M.D.,Ph.D.

Blood (2006) 108 (11): 1449.

https://doi.org/10.1182/blood.V108.11.1449.1449

Published: 2006

Journal Articles

RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection

Richard L. Bennett, William L. Blalock, Dean M. Abtahi, Yu Pan, Sue A. Moyer, W. Stratford May

Blood (2006) 108 (3): 821–829.

https://doi.org/10.1182/blood-2005-11-006817

Published: 2006

Journal Articles

Targeting Lyn Kinase with Short Interfering RNA (siRNA)-A Novel Therapeutic Strategy for Drug Resistant Chronic Myelogenous Leukemia (CML).

Andrzej Ptasznik, MD, PhD., Yuji Nakata, MD, Anna Kalota, Stephen G. Emerson, MD, PhD., Alan M. Gewirtz, MD

Blood (2004) 104 (11): 554.

https://doi.org/10.1182/blood.V104.11.554.554

Published: 2004

Journal Articles

The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality

Qishen Pang, Tracy A. Christianson, Winifred Keeble, Jane Diaz, Gregory R. Faulkner, Carol Reifsteck, Susan Olson, Grover C. Bagby

Blood (2001) 98 (5): 1392–1401.

https://doi.org/10.1182/blood.V98.5.1392

Published: 2001

Journal Articles

Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon γ, tumor necrosis factor-α, and double-stranded RNA

Qishen Pang, Winifred Keeble, Jane Diaz, Tracy A. Christianson, Sara Fagerlie, Keaney Rathbun, Gregory R. Faulkner, Michael O'Dwyer, Grover C. Bagby, Jr

Blood (2001) 97 (6): 1644–1652.

https://doi.org/10.1182/blood.V97.6.1644

Published: 2001

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Angiogenesis Induced By Aminoacyl-tRNA Synthetase Deficiency Is Dependent on Amino Acid Response (AAR) but Not Unfolded Protein Response (UPR) Pathways

Domain-Focused CRISPR-Cas9 Screen Identifies Hri Kinase As a Regulator of Fetal Hemoglobin in Adult Human Erythroid Cells

Identification of Imatinib-Sensitizing Genes in Chronic Myeloid Leukemia with a Genome-Scale Crispr Knock-out Screen

Abnormal Expression of Friend Leukemia Virus Integration 1 (Fli1) Protein Is An Adverse Prognostic Factor In AML.

Constitutive Activation of FRAP/mTOR Pathway in Pediatric Anaplastic Large Cell Lymphomas: Potential Role as a Therapeutic Target.

Endoplasmic Reticulum Stress Is a Target for Therapy in Waldenstrom’s Macroglobulinemia (WM).

RAX Activates Tumor Suppressor p53.

RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection

Targeting Lyn Kinase with Short Interfering RNA (siRNA)-A Novel Therapeutic Strategy for Drug Resistant Chronic Myelogenous Leukemia (CML).

The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality

Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon γ, tumor necrosis factor-α, and double-stranded RNA

Email alerts

ASH Publications

American Society of Hematology